Altius Renewable Royalties Corp. (TSE:ARR – Get Free Report) shot up 2.3% during mid-day trading on Friday . The company traded as high as C$9.18 and last traded at C$9.18. 81,160 shares were traded during mid-day trading, an increase of 551% from the average session volume of 12,466 shares. The stock had previously closed at C$8.97.
Analyst Ratings Changes
Separately, TD Securities boosted their target price on shares of Altius Renewable Royalties from C$11.50 to C$12.50 and gave the stock a “buy” rating in a report on Friday, March 1st. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of C$11.90.
Altius Renewable Royalties Stock Performance
Altius Renewable Royalties (TSE:ARR – Get Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The company reported C($0.01) earnings per share for the quarter, missing the consensus estimate of C$0.04 by C($0.05). Altius Renewable Royalties had a negative return on equity of 0.60% and a negative net margin of 227.79%. The business had revenue of C$1.47 million during the quarter, compared to the consensus estimate of C$1.50 million. As a group, equities analysts forecast that Altius Renewable Royalties Corp. will post 0.0482034 earnings per share for the current year.
About Altius Renewable Royalties
Altius Renewable Royalties Corp., a renewable energy royalty company, engages in the acquisition and management of renewable energy investments and royalties in North America. The company holds interests in a portfolio of 2,068 MW of operational wind, solar, and hydroelectric projects located in Texas, Kansas, California, and Vermont.
Recommended Stories
- Five stocks we like better than Altius Renewable Royalties
- What Are Dividend Contenders? Investing in Dividend Contenders
- McDonald’s Stock: Balancing Value and Innovation
- Transportation Stocks Investing
- MarketBeat Week in Review – 6/17 – 6/21
- Business Services Stocks Investing
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Altius Renewable Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altius Renewable Royalties and related companies with MarketBeat.com's FREE daily email newsletter.